Recruiting
Double hit lymphoma+7
RecruitingStudy on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma
Registered drugNo placebo
Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma
Registered drugNo placebo
- Disease:Double hit lymphomaDiffuse large B-cell lymphoma+6
- Substances:AcalabrutinibCyclophosphamide+6
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Acalabrutinib
- Sponsor:Universitaet Des Saarlandes

